Circling back to the topic of how precision medicine-oriented data can best serve public health interest, JNCI recently ran a commentary and primary research article on BRCA1 and BRCA2 screening in the context of public health interests in the Ashkenazi population (jnci.oxfordjournals.org/conten...). Would something like this -- whether BRCA testing or otherwise -- be implementable or cost-effective in the US? How could precision medicine inform these efforts?
Sandro Galea, MD, MPH, DrPH
Dean and Professor at Boston University School of Public Health
Mary Carol Jennings, MD, MPH
Public Health Physician
Medical Student at University of Pittsburgh School of Medicine
- All Questions & Answers
- Question: Day 9: Where will genetic data best serve public health?
Affiliations of authors: Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel (ELL); Faculty of Medicine, Hebrew University Medical School, Jerusalem, Israel (ELL, AL); Depart... Read More